In vivo rapid reduction of alloantigen-activated CD8+ mature cytotoxic T cells by inhibitors of acidification of intracellular organelles, prodigiosin 25-C and concanamycin B

Immunology

Volumn 99, Issue 2, 2000, Pages 243-248

  Lee, M H ^a,b   Kataoka, T ^a   Honjo, N ^c   Magae, J ^a,c   Nagai, K ^a  

^a TOKYO INSTITUTE OF TECHNOLOGY   (Japan)

^b CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

^c INSTITUTE OF RESEARCH AND INNOVATION   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALLOANTIGEN; ANTIBODY; CD8 ANTIGEN; CONCANAMYCIN B; IMMUNOSUPPRESSIVE AGENT; PERFORIN; PRODIGIOSIN; PRODIGIOSIN 25C; TACROLIMUS; UNCLASSIFIED DRUG;

ACIDIFICATION; ANIMAL CELL; ANIMAL EXPERIMENT; ANTIBODY TITER; ARTICLE; CELL MEDIATED CYTOTOXICITY; CELL ORGANELLE; CELL STIMULATION; COMPETITIVE INHIBITION; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; LYMPHOCYTE SUBPOPULATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; SPLEEN CELL; T LYMPHOCYTE ACTIVATION;

ANIMALS; ANTI-BACTERIAL AGENTS; CD8-POSITIVE T-LYMPHOCYTES; CYTOTOXICITY, IMMUNOLOGIC; FEMALE; HYDROGEN-ION CONCENTRATION; IMMUNE TOLERANCE; IMMUNOSUPPRESSIVE AGENTS; ISOANTIGENS; LYMPHOCYTE COUNT; MACROLIDES; MICE; MICE, INBRED C57BL; ORGANELLES; PRODIGIOSIN;

EID: 0033974672     PISSN: 00192805     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2567.2000.00961.x     Document Type: Article

References (36)

1. 1. Harashima K., Tsuchida N., Tanaka T. & Nagatsu J. (1967) Prodigiosin 25-C: isolation and the chemical structure. Agric Biol Chem 31, 481.
2. 2. Wasserman H.H., Rodgers G.C. & Keith D.D. (1976) Undecylprodigiosin. Tetrahedron 32, 1851.
3. 3. Nakamura A., Nagai K., Ando K. & Tamura G. (1986) Selective suppressíon by prodigiosin of the mitogenic response of murine splenocytes. J Antibiot 39, 1151.
4. 4. Tsuji R.F., Yamamoto M., Nakamura A. et al. (1990) Selective immunosuppression of prodigiosin 25-C and FK506 in the murine immune system. J Antibiot 43, 1293.
5. 5. Kataoka T., Magae J., Nariuchi H., Yamasaki M. & Nagai K. (1992) Enhancement by concanavalin A of the suppressive effect of prodigiosin 25-C on proliferation of murine splenocytes. J Antibiot 45, 1301.
6. 6. Nakamura A., Magae J., Tsuji R.F., Yamasaki M. & Nagai K. (1989) Suppression of cytotoxic T cell induction in vivo by prodigiosin 25-C. Transplantation 47, 1013.
7. 7. Tsuji R.F., Magae J., Yamashita M., Nagai K. & Yamasaki M. (1992) Immunomodulating properties of prodigiosin 25-C, an antibiotic which preferentially suppresses induction of cytotoxic T cells. J Antibiot 45, 1295.
8. 8. Magae J., Miller M.M., Nagai K. & Shearer G.M. (1996) Effect of metacycloprodigiosin, an inhibitor of killer T cells, on murine skin and heart transplants. J Antibiol 49, 86.
9. 9. Songia S., Mortellaro A., Taverna S. et al. (1997) Characterization of the new immunosuppressive drug undecylprodigiosin in human lymphocytes: retinoblastoma protein, cyclin-dependent kinase-2, and cyclin-dependent kinase-4 as molecular targets. J Immunol 158, 3987.
10. 10. Flanagan W.M., Corthesy B., Bram R.J. & Crabtree G.R. (1991) Nuclear association of a T-cell transcription factor blocked by FK-506 and cyclosporin A. Nature 352, 803.
11. 11. Liu J., Farmer J.D. Jr, Lane W.S., Friedman J., Weissman I. & Schreiber S.L. (1991) Calcineurin is a common target of cyclophilin cyclosporin A and FKBP-FK506 complexes. Cell 66, 807.
12. 12. Larsson E.-J. (1980) Cyclosporin A and dexamethasone suppress T cell responses by selectively acting at distinct sites of the triggering process. J Immunol 124, 2828.
13. 13. Shevach E. (1985) The effects of cyclosporin A on the immune system. Annu Rev Immunol 3, 397.
14. 14. Sigal N.H. & Dumont F.J. (1992) Cyclosporin A, FK-506, and rapamycin: pharmacologic probes of lymphocyte signal transduction. Annu Rev Immunol 10, 519.
15. 15. Kino T., Hatanaka H., Miyata S. et al. (1987) FK-506, a novel immunosuppressant isolated from a Streptomyces. II. Immunosuppressive effect of FK-506 in vitro. J Antibiot 40, 1256.
16. 16. Sawada S., Suzuki G., Kawase Y. & Takaku F. (1987) Novel immunosuppressive agent, FK506. In vitro effects on the cloned T cell activation. J Immunol 139, 1797.
17. 17. Tocci M.J., Matkovich D.A., Collier K.A. et al. (1989) The immunosuppressant FK506 selectively inhibits expression of early T cell activation genes. J Immunol 143, 718.
18. 18. Bowman E.J., Shiebers A. & Altendorf K. (1988) Bafilomycins: a class of inhibitors of membrane ATPases from microorganisms, animal cells, and plant cells. Proc Natl Acad Sci USA 85, 7972.
19. 19. Woo J.-T., Shinohara C., Sakai K., Hasumi K. & Endo A. (1992) Inhibition of the acidification of endosomes and lysosomes by the antibiotic concanamycin B in macrophage J774. Eur J Biochem 207, 383.
20. + -ATPase inhibitors. J Antibiot 45, 1618.
21. 21. Mellman I., Fucks R. & Helenius A. (1986) Acidification of the endocytic and exocytic pathways. Annu Rev Biochem 55, 663.
22. 22. Kataoka T., Takaku K., Magae J. et al. (1994) Acidification is essential for maintaining the structure and function of lytic granules of CTL. J Immunol 153, 3938.
23. 23. Kataoka T., Togashi K., Takayama H., Takaku K. & Nagai K. (1997) Inactivation and proteolytic degradation of perforin within lytic granules upon neutralization of acidic pH. Immunol 91, 493.
24. 24. Togashi K., Kataoka T. & Nagai K. (1997) Characterization of a series of vacuolar type H +-ATPase inhibitors on CTL-mediated cytotoxicity. Immunol Lett 55, 139.
25. 25. Kataoka T., Muroi M., Ohkuma S. et al. (1995) Prodigiosin 25-C uncouples vacuolar type H ' -ATPase, inhibits vacuolar acidification and affects glycoprotein processing. FEBS Lett 359, 53.
26. + /Cl symporters that uncouple proton translocators. J Biol Chem 273, 21455.
27. 27. Lee M.-H., Kataoka T., Magae J. & Nagai K. (1995) Prodigiosin 25-C suppression of cytotoxic T cells in vitro and in vivo is similar to that of concanamycin B, a specific inhibitor of vacuolar type H (+)-ATPase. Biosci Biotech Biochem 59, 1417.
28. 28. Magae J., Illenye S., Tejima T. et al. (1997) Transcriptional squelching by ectopic expression of E2F-1 and p53 is alleviated by proteasome inhibitors MG-132 and lactacystin. Oncogene 15, 759.
29. 29. Lee M.-H., Yamashita M., Tsuji R.F. et al. (1998) Suppression of T cell stimulating function of allogeneic antigen presenting cells by prodigiosin 25-C. J Antibiot 51, 92.
30. 30. Hayes M.P., Berrebi G.A. & Henkart P.A. (1989) Induction of target cell DNA release by the cytotoxic T lymphocyte granule protease granzyme A. J Exp Med 170, 933.
31. 31. Shi L., Kraut R.P., Aebersold R. & Greenberg, A.H. (1992) A natural killer cell granule protein that induces DNA fragmentation and apoptosis. J Exp Med 175, 553.
32. 32. Shi L., Kam C.M., Powers J.C., Aebersold R. & Greenberg A.H. (1992) Purification of three cytotoxic lymphocyte granule serine proteases that induce apoptosis through distinct substrate and target cell interactions. J Exp Med 176, 1521.
33. + CTL. Cytotechnology 25, 127.
34. 34. Stalder T., Hahn S. & Erb P. (1994) Fas antigen is the major target molecule for CD4+ T cell-mediated cytotoxicity. J Immunol 152, 1127.
35. + cytotoxic T cells. Proc Natl Acad Sci USA 91, 4185.
36. 36. Kataoka T., Shinohara N., Takayama H. et al. (1996) Concanamycin A, a powerful tool for characterization and estimation of contribution of perforin-and Fas-based lytic pathways in cell-mediated cytotoxicity. J Immunol 156, 3678.